International union of basic and clinical pharmacology CIII: chemerin receptors CMKLR1 (Chemerin1) and GPR1 (Chemerin2) nomenclature, pharmacology, and …

AJ Kennedy, AP Davenport - Pharmacological Reviews, 2018 - ASPET
Chemerin, a chemoattractant protein and adipokine, has been identified as the endogenous
ligand for a G protein–coupled receptor encoded by the gene CMKLR1 (also known as …

Chemerin Elicits Potent Constrictor Actions via Chemokine‐Like Receptor 1 (CMKLR 1), not G‐Protein‐Coupled Receptor 1 (GPR 1), in Human and Rat Vasculature

AJ Kennedy, P Yang, C Read, RE Kuc… - Journal of the …, 2016 - Am Heart Assoc
Background Circulating levels of chemerin are significantly higher in hypertensive patients
and positively correlate with blood pressure. Chemerin activates chemokine‐like receptor 1 ( …

[HTML][HTML] Protease-activated receptor-2 ligands reveal orthosteric and allosteric mechanisms of receptor inhibition

AJ Kennedy, L Sundström, S Geschwindner… - Communications …, 2020 - nature.com
Protease-activated receptor-2 (PAR2) has been implicated in multiple pathophysiologies
but drug discovery is challenging due to low small molecule tractability and a complex …

[HTML][HTML] Characterization of homologous sphingosine-1-phosphate lyase isoforms in the bacterial pathogen Burkholderia pseudomallei

…, R Custodio, J Lowther, AJ Kennedy, J Pollock… - Journal of lipid …, 2017 - ASBMB
Sphingolipids (SLs) are ubiquitous elements in eukaryotic membranes and are also found in
some bacterial and viral species. As well as playing an integral structural role, SLs also act …

Structural characterization of agonist binding to protease-activated receptor 2 through mutagenesis and computational modeling

AJ Kennedy, F Ballante, JR Johansson… - ACS Pharmacology & …, 2018 - ACS Publications
Protease-activated receptor 2 (PAR2) is a G-protein-coupled receptor that is activated by
proteolytic cleavage of its N-terminus. The unmasked N-terminal peptide then binds to the …

Toward personalized medicine in schizophrenia: Genetics and epigenetics of antipsychotic treatment

…, CC Chen, CC Zai, AK Tiwari, JL Kennedy - Schizophrenia …, 2021 - Elsevier
Schizophrenia is a complex psychiatric disorder where genetic, epigenetic, and environmental
factors play a role in disease onset, course of illness, and treatment outcome. Pharmaco(…

DNA methylation and clinical response to antidepressant medication in major depressive disorder: a review and recommendations

AJ Lisoway, CC Zai, AK Tiwari, JL Kennedy - Neuroscience letters, 2018 - Elsevier
Antidepressant medications are the most common treatment for major depression and
related disorders. Pharmacogenetic studies have demonstrated that response to these …

Characterisation of homologous sphingosine 1-phosphate lyase (S1PL) isoforms in the bacterial pathogen Burkholderia pseudomallei.

…, J Marles-Wright, R Custodio, J Lowther, AJ Kennedy… - 2016 - ore.exeter.ac.uk
Sphingolipids (SLs) are ubiquitous elements in eukaryotic membranes and are also found in
some bacterial and viral species. As well as playing an integral structural role, SLs also act …

Towards precision medicine in generalized anxiety disorder: Review of genetics and pharmaco (epi) genetics

…, GCM Zai, RE McCabe, MA Richter, JL Kennedy… - Journal of psychiatric …, 2019 - Elsevier
Generalized anxiety disorder (GAD) is a prevalent and chronic mental disorder that elicits
widespread functional impairment. Given the high degree of non-response/partial response …

Antidepressant-associated mania in bipolar disorder: a review and meta-analysis of potential clinical and genetic risk factors

…, DJ Mueller, CC Zai, JL Kennedy - Journal of Clinical …, 2020 - journals.lww.com
Purposes/Background: Antidepressants (ADs) play a valuable role in treating the depressive
episodes of bipolar disorder. However, 14% of these individuals taking ADs experience AD-…